S SRINIVASA RAO's Insider Trades & SAST Disclosures
S SRINIVASA RAO's most recent trade in CCL Products India Ltd. was a Disposal of 20,995 Equity Shares done at an average price of Rs. 764.7 . Disclosure was reported to the exchange on May 19, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
S SRINIVASA RAO's has made SAST transactions in Telogica Ltd. recently where a Acquisition of 1,679,090 shares done . Disclosure was reported to the exchange on April 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern S SRINIVASA RAO.To see full superstar portfolios of large investors like Jhunjhunwala, Damani and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CCL Products | SRINIVASA RAO PATURI | Designated Person | Disposal | 19 May 2025 | 20,995 | 245,000 (0.18%) | 0.02% | 764.7 | 16,055,232 | 16 May 2025 16 May 2025 |
Insider Trading | Equity Shares | Market Sale |
| Telogica | Srinivasa Rao Mandava | Promoter | Acquisition | 24 Apr 2025 | 1,679,090 | 8,190,688 (24.25%) | 4.97% | - | 31 Mar 2025 31 Mar 2025 |
SAST (29(2)) | - | Conv. of Warrants | |
| Telogica | Mandava Srinivasa Rao | Promoter & Director | Acquisition | 02 Apr 2025 | 1,679,090 | 8,190,688 (24.25%) | 5.31% | 8 | 13,432,720 | 31 Mar 2025 31 Mar 2025 |
Insider Trading | Equity Shares | Conversion of security |
| Diligent Industries | Srinivasa Rao Paturi | Other | Acquisition | 07 Jan 2025 | 4,167,000 | 12,667,000 (5.31%) | 1.75% | - | 23 Dec 2024 23 Dec 2024 |
SAST (29(2)) | - | Rights Issue | |
| Exicom Tele-Systems | Srinivasa Rao Saripalli | Designated Person | Disposal | 20 Sep 2024 | 60,000 | 341,079 (0.28%) | 0.05% | 317.9 | 19,072,800 | 19 Sep 2024 19 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
| Exicom Tele-Systems | Srinivasa Rao Saripalli | Designated Person | Disposal | 19 Sep 2024 | 41,000 | 426,079 (0.35%) | 0.03% | 333.8 | 13,687,030 | 17 Sep 2024 17 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
| Exicom Tele-Systems | Srinivasa Rao Saripalli | Designated Person | Disposal | 19 Sep 2024 | 25,000 | 401,079 (0.33%) | 0.02% | 335.0 | 8,376,000 | 18 Sep 2024 18 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
| Exicom Tele-Systems | Srinivasa Rao Saripalli | Designated Person | Disposal | 17 Sep 2024 | 1,643 | 467,079 (0.39%) | 0.00% | 349 | 573,407 | 16 Sep 2024 16 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
| Exicom Tele-Systems | Srinivasa Rao Saripalli | Designated Person | Disposal | 16 Sep 2024 | 12,745 | 468,722 (0.39%) | 0.01% | 356.3 | 4,540,916 | 13 Sep 2024 13 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
| Exicom Tele-Systems | Srinivasa Rao Saripalli | Designated Person | Disposal | 16 Sep 2024 | 34,053 | 481,467 (0.40%) | 0.03% | 358.4 | 12,203,574 | 11 Sep 2024 11 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
| Exicom Tele-Systems | Srinivasa Rao Saripalli | Designated Person | Disposal | 16 Sep 2024 | 2,000 | 515,680 (0.43%) | 0.00% | 342 | 684,000 | 09 Sep 2024 09 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
| Exicom Tele-Systems | Srinivasa Rao Saripalli | Designated Person | Disposal | 16 Sep 2024 | 160 | 515,520 (0.43%) | 0.00% | 343.1 | 54,893 | 10 Sep 2024 10 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVASA RAO S | Designated Person | Disposal | 28 Jun 2024 | 1,950 | 50 (0%) | 0.00% | 1812.3 | 3,533,946 | 27 Jun 2024 27 Jun 2024 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVASA RAO S | Designated Person | Disposal | 28 Jun 2024 | 1,000 | 2,000 (0%) | 0.00% | 1822 | 1,822,000 | 25 Jun 2024 25 Jun 2024 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | SRINIVASA RAO S | Designated Person | Disposal | 26 Jun 2024 | 1,000 | 3,000 (0%) | 0.00% | 1825 | 1,825,000 | 24 Jun 2024 24 Jun 2024 |
Insider Trading | Equity Shares | Market Sale |
| Mahindra & Mahindra | Kadiam Srinivasa Rao | Designated Person | Acquisition | 14 May 2024 | 3,804 | 13,484 (0%) | 0.00% | 2270.5 | 8,637,172 | 14 May 2024 14 May 2024 |
Insider Trading | Equity Shares | ESOP |
| CCL Products | SRINIVASA RAO PATURI | Other | Disposal | 01 Jan 2024 | 6,700 | 315,995 (0.24%) | 0.01% | 630.7 | 4,225,752 | 29 Dec 2023 29 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| CCL Products | SRINIVASA RAO PATURI | Other | Disposal | 29 Dec 2023 | 3,262 | 322,695 (0.24%) | 0.00% | 641.4 | 2,092,184 | 26 Dec 2023 27 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 18 Dec 2023 | 4,000 | 4,000 (0%) | 0.00% | 1817.6 | 7,270,397 | 14 Dec 2023 14 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Telogica | Mandava Srinivasa Rao | Promoter | Acquisition | 25 May 2023 | 1,000 | 5,977,598 (25.01%) | - | - | 26 Apr 2023 26 Apr 2023 |
SAST (29(2)) | - | Open Offer | |
| Telogica | Mandava Srinivasa Rao | Promoter | Acquisition | 25 May 2023 | 530,000 | 6,507,598 (27.23%) | 2.21% | - | 09 May 2023 09 May 2023 |
SAST (29(2)) | - | Open Offer | |
| Telogica | Mandava Srinivasa Rao | Promoter | Acquisition | 21 Apr 2023 | 4,743,026 | 4,743,026 (19.85%) | 19.85% | - | 29 Mar 2023 29 Mar 2023 |
SAST (29(2)) | - | Open Offer | |
| Telogica | Mandava Srinivasa Rao | Promoter | Acquisition | 21 Apr 2023 | 1,233,572 | 5,976,598 (25.01%) | 5.16% | - | 17 Apr 2023 17 Apr 2023 |
SAST (29(2)) | - | Open Offer | |
| Aurobindo Pharma | Srinivasa Rao Karimikonda | Designated Person | Disposal | 05 Apr 2023 | 2,500 | 0 (0%) | 0.00% | 518.6 | 1,296,462 | 28 Mar 2023 31 Mar 2023 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 03 Jan 2022 | 1,000 | 8,500 (0%) | 0.00% | 3941.5 | 3,941,460 | 30 Dec 2021 30 Dec 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 03 Jan 2022 | 500 | 9,500 (0.01%) | 0.00% | 3920 | 1,960,000 | 29 Dec 2021 29 Dec 2021 |
Insider Trading | Equity Shares | Market Sale |
| Arunjyoti Bio Ventures | Kaja Srinivasa Rao | Other | Acquisition | 10 Dec 2022 | 187,595 | 189,677 (9.16%) | 9.06% | - | 30 Dec 2021 30 Dec 2021 |
SAST (29(1)) | - | Off Market | |
| Likhitha Infra | Srinivasa Rao Gaddipati | Promoter | Disposal | 07 Dec 2022 | 806,000 | 13,445,250 (68.17%) | 4.08% | - | 30 Nov 2022 30 Nov 2022 |
SAST (29(2)) | - | Market | |
| Likhitha Infra | Srinivasa Rao Gaddipati | Promoter | Disposal | 02 Dec 2022 | 806,000 | 13,445,250 (68.17%) | 2.04% | 387.5 | 312,362,514 | 30 Nov 2022 30 Nov 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 04 Jul 2022 | 1,500 | 8,000 (0%) | 0.00% | 2694.0 | 4,041,060 | 30 Jun 2022 30 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 30 Jun 2022 | 1,000 | 9,500 (0.01%) | 0.00% | 2669 | 2,669,000 | 28 Jun 2022 28 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 28 Jun 2022 | 500 | 10,500 (0.01%) | 0.00% | 2672.2 | 1,336,100 | 27 Jun 2022 27 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 23 Jun 2022 | 1,000 | 0 (0%) | 0.00% | 2676.4 | 2,676,370 | 22 Jun 2022 22 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 23 Jun 2022 | 100 | 1,000 (0%) | 0.00% | 2653.6 | 265,357 | 21 Jun 2022 21 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 23 Jun 2022 | 1,000 | 11,000 (0.01%) | 0.00% | 2675 | 2,675,000 | 21 Jun 2022 21 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 21 Jun 2022 | 500 | 1,100 (0%) | 0.00% | 2660 | 1,330,000 | 16 Jun 2022 16 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 17 Jun 2022 | 500 | 1,600 (0%) | 0.00% | 2702.1 | 1,351,070 | 15 Jun 2022 15 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Acquisition | 16 Jun 2022 | 3,500 | 12,000 (0.01%) | 0.00% | 542 | 1,897,000 | 15 Jun 2022 15 Jun 2022 |
Insider Trading | Equity Shares | ESOP |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Acquisition | 04 May 2022 | 2,100 | 2,100 (0%) | 0.00% | 542 | 1,138,200 | 29 Apr 2022 29 Apr 2022 |
Insider Trading | Equity Shares | ESOP |
| Natco Pharma | BIKKUMALLA SRINIVASA RAO | Designated Person | Disposal | 04 Mar 2022 | 350 | 0 (0%) | 0.00% | 884 | 309,400 | 03 Mar 2022 03 Mar 2022 |
Insider Trading | Equity Shares | Market Sale |
| IIFL Finance | Srinivasa Rao Rekapalli | Designated Person | Disposal | 07 Feb 2022 | 3,000 | 6,720 (0%) | 0.00% | 352.7 | 1,058,000 | 02 Feb 2022 03 Feb 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 30 Dec 2021 | 100 | 10,000 (0.01%) | 0.00% | 3914.5 | 391,450 | 24 Dec 2021 24 Dec 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 24 Dec 2021 | 900 | 10,100 (0.01%) | 0.00% | 3850.1 | 3,465,063 | 23 Dec 2021 23 Dec 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 24 Dec 2021 | 200 | 11,000 (0.01%) | 0.00% | 3765 | 753,000 | 20 Dec 2021 20 Dec 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 15 Aug 2021 | 500 | 11,200 (0.01%) | 0.00% | 4325.1 | 2,162,565 | 12 Aug 2021 12 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 15 Aug 2021 | 700 | 11,700 (0.01%) | 0.00% | 4196.7 | 2,937,718 | 10 Aug 2021 10 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Laurus Labs | SRINIVASA RAO SURYADEVARA | Designated Person | Disposal | 13 Aug 2021 | 20,000 | 276,145 (0.10%) | 0.00% | 700 | 14,000,000 | 10 Aug 2021 11 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Laurus Labs | SRINIVASA RAO SURYADEVARA | Designated Person | Disposal | 13 Aug 2021 | 67,657 | 820,108 (0.15%) | 0.01% | 702.9 | 47,555,590 | 11 Aug 2021 11 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Laurus Labs | SRINIVASA RAO SURYADEVARA | Designated Person | Disposal | 13 Aug 2021 | 18,120 | 887,765 (0.17%) | 0.00% | 703.3 | 12,743,294 | 10 Aug 2021 10 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 11 Aug 2021 | 4,550 | 350 (0%) | 0.00% | 4040 | 18,382,000 | 09 Aug 2021 09 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 11 Aug 2021 | 350 | 0 (0%) | 0.00% | 4227.5 | 1,479,632 | 10 Aug 2021 10 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 07 Aug 2021 | 800 | 12,400 (0.01%) | 0.00% | 4090 | 3,272,000 | 05 Aug 2021 05 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 29 Jul 2021 | 700 | 13,200 (0.01%) | 0.00% | 4037.1 | 2,825,998 | 26 Jul 2021 26 Jul 2021 |
Insider Trading | Equity Shares | Market Sale |
| Laurus Labs | SRINIVASA RAO SURYADEVARA | Designated Person | Pledge | 30 Jun 2021 | 70,000 | 296,145 (0.05%) | 0.01% | 680 | 47,600,000 | 29 Jun 2021 29 Jun 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Laurus Labs | SRINIVASA RAO SURYADEVARA | Designated Person | Pledge | 29 Jun 2021 | 220,000 | 905,885 (0.17%) | 0.04% | 650 | 143,000,000 | 28 Jun 2021 28 Jun 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Gland Pharma | S. SRINIVASA RAO | Designated Person | Disposal | 31 May 2021 | 500 | 11,100 (0.01%) | 0.00% | 3275 | 1,637,500 | 28 May 2021 28 May 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | S SRINIVASA RAO | Designated Person | Disposal | 26 May 2021 | 300 | 11,600 (0.01%) | 0.00% | 3266.8 | 980,025 | 25 May 2021 25 May 2021 |
Insider Trading | Equity Shares | Market Sale |
| IIFL Finance | Srinivasa Rao R | Designated Person | Disposal | 01 Apr 2021 | 6,500 | 3,220 (0%) | 0.00% | 281 | 1,826,500 | 31 Mar 2021 31 Mar 2021 |
Insider Trading | Equity Shares | Market Sale |
| IIFL Finance | Srinivasa Rao R | Designated Person | Acquisition | 19 Mar 2021 | 9,720 | 9,720 (0%) | 0.00% | 106.7 | 1,036,832 | 16 Mar 2021 16 Mar 2021 |
Insider Trading | Equity Shares | ESOP |
| Ortin Global | Gaddam Srinivasa Rao | Other | Disposal | 28 Jan 2021 | 36,234 | 33,446 (0.41%) | - | - | 23 Jan 2021 23 Jan 2021 |
SAST (29(2)) | - | Sch.of Arrangement | |
| Ortin Global | Gaddam Srinivasa Rao | Other | Disposal | 27 Jan 2021 | 36,234 | 33,446 (0.41%) | 0.21% | 10 | 362,340 | 23 Jan 2021 23 Jan 2021 |
Insider Trading | Equity Shares | Scheme of Amalgamation/Merger/Demerger/Arrangement |
| Divi's Laboratories | R. Srinivasa Rao | Designated Person | Disposal | 05 Jan 2021 | 304 | 1 (0%) | 0.00% | 3448.2 | 1,048,242 | 15 Oct 2020 23 Nov 2020 |
Insider Trading | Equity Shares | Market Sale |
| Divi's Laboratories | R. Srinivasa Rao | Designated Person | Acquisition | 05 Jan 2021 | 125 | 305 (0%) | 0.00% | 3248.1 | 406,010 | 15 Oct 2020 23 Nov 2020 |
Insider Trading | Equity Shares | Market Purchase |
| Dhani Services | SRINIVASA RAO KUCHIPUDI | Employee | Disposal | 04 Jan 2021 | 7,400 | 5,000 (0.01%) | 0.00% | 330.8 | 2,448,000 | 28 Dec 2020 31 Dec 2020 |
Insider Trading | Equity Shares | Market Sale |
| Laurus Labs | Srinivasa Rao Suryadevara | Designated Person | Acquisition | 02 Jan 2021 | 5,000 | 299,645 (0.17%) | 0.00% | 335.7 | 1,678,600 | 22 Dec 2020 22 Dec 2020 |
Insider Trading | Equity Shares | ESOP |
| Laurus Labs | Srinivasa Rao S | Designated Person | Acquisition | 02 Jan 2021 | 10,000 | 905,885 (0.06%) | 0.00% | 335.7 | 3,357,200 | 22 Dec 2020 22 Dec 2020 |
Insider Trading | Equity Shares | ESOP |
| Dhani Services | SRINIVASA RAO KUCHIPUDI | Employee | Disposal | 29 Dec 2020 | 9,100 | 12,400 (0%) | 0.00% | 318.5 | 2,898,055 | 24 Dec 2020 24 Dec 2020 |
Insider Trading | Equity Shares | Market Sale |
| CCL Products | Paturi Srinivasa Rao | Connected Person | Disposal | 17 Dec 2020 | 2,305 | 330,957 (0.25%) | 0.00% | 260.5 | 600,456 | 15 Dec 2020 16 Dec 2020 |
Insider Trading | Equity Shares | Market Sale |
| CCL Products | Paturi Srinivasa Rao | Connected Person | Disposal | 17 Dec 2020 | 7,695 | 333,262 (0.25%) | 0.01% | 260.9 | 2,007,498 | 11 Dec 2020 14 Dec 2020 |
Insider Trading | Equity Shares | Market Sale |
| Laurus Labs | SRINIVASA RAO SUDIREDDY | Employee | Disposal | 19 Nov 2020 | 4,000 | 0 (0%) | 0.00% | 275.3 | 1,101,303 | 18 Nov 2020 18 Nov 2020 |
Insider Trading | Equity Shares | Market Sale |
| Dr. Reddy's Labs | Srinivasa Rao | Designated Person | Acquisition | 30 Oct 2020 | 2,375 | 2,375 (0%) | 0.00% | 4874.9 | 11,577,907 | 27 Oct 2020 27 Oct 2020 |
Insider Trading | Equity Shares | ESOP |
| Avantel | Pusuluru Srinivasa Rao | Designated Person | Disposal | 28 Sep 2020 | 3,796 | 34 (0%) | 0.09% | 387.7 | 1,471,579 | 29 Jul 2020 25 Sep 2020 |
Insider Trading | Equity Shares | Market Sale |
| Laurus Labs | SRINIVASA RAO SURYADEVARA | Designated Person | Disposal | 21 Sep 2020 | 1,500 | 58,929 (0.05%) | 0.00% | 1348.1 | 2,022,144 | 16 Sep 2020 17 Sep 2020 |
Insider Trading | Equity Shares | Market Sale |
| Laurus Labs | SRINIVASA RAO SURYADEVARA | Designated Person | Acquisition | 18 Jul 2020 | 10,000 | 179,177 (0.17%) | 0.01% | 626.7 | 6,267,000 | 16 Jul 2020 16 Jul 2020 |
Insider Trading | Equity Shares | ESOP |
| Laurus Labs | SRINIVASA RAO SURYADEVARA | Designated Person | Acquisition | 18 Jul 2020 | 5,000 | 60,929 (0.06%) | 0.00% | 626.7 | 3,133,500 | 16 Jul 2020 16 Jul 2020 |
Insider Trading | Equity Shares | ESOP |
| Dr. Reddy's Labs | Srinivasa Rao | Employee | Acquisition | 01 Jul 2020 | 1,244 | 1,844 (0%) | 0.00% | 4030.2 | 5,013,507 | 27 Jun 2020 27 Jun 2020 |
Insider Trading | Equity Shares | ESOP |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.